Stocks end higher Tuesday as investors track a busy slate of corporate earnings.

Atea Pharmaceuticals could shed more than $2 billion in value Tuesday after the drugmaker said a mid-stage trial of its developing COVID treatment failed to meet expectations.

AstraZeneca, Brooks Automation, Teradata, Atea Pharmaceuticals and Astronics are five top stock gainers for Monday.

Astea International (ATEA) stock is higher after it announced a two-year $3 million revolving credit line from Silicon Valley Bank (SIVB).

Astea International (ATEA) stock is spiking on Tuesday after being awarded a contract to implement Astea Alliance for an unnamed leading global IT services company.

Target brings in a famous partner to expand designs.

Chick-fil-A is offering more variety in a new concept.

The Indian tycoon and his empire are facing allegations of fraud by an American short-seller. Their answer does not convince investors for the moment.

The billionaire had proposed a controversial plan to end the Russia-Ukraine conflict, which now has lasted nearly a year.